Dr. Marty Makary pointed out the Biden administration's decision to skip key committee meetings when authorizing vaccines, in response to a top Democrat's question.
Marty Makary, President Donald Trump’s pick to oversee US food and drug regulation, faced pointed questions in a Senate ...
Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...
The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.
14h
Axios on MSNStates push fight against mRNA vaccinesThe mRNA vaccines that helped to end the COVID pandemic — and stoked a considerable amount of vaccine skepticism and ...
Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and ...
It has been five years since the World Health Organisation (WHO) declared COVID-19 a pandemic in March 2020 a decision that ...
Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more.
Dr. Jay Bhattacharya told Sen. Josh Hawley that he supports developing alternatives for vaccines and therapeutics that use aborted cell lines.
Public health experts discuss lessons learned from the U.S. response to the COVID pandemic, on topics ranging from school ...
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results